Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Eli Lilly and Company Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 76.51||$ 92.85|
|Low||$ 75.10||$ 67.88|
The current last sale of $75.53 is 11.27% Higher thanthe 52 week low.
ETFs with LLY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|6.29%||iShares U.S. Pharmaceutical ETF (IHE)||-16.43 (-10.31%)|
|5.4%||PowerShares Dynamic Pharmaceuticals (PJP)||-8.23 (-11.47%)|
|4.25%||SPDR S&P Pharmaceuticals ETF (XPH)||-10.04 (-18.96%)|
|1.88%||Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH)||+1.69 (1.14%)|
Company Description (as filed with the SEC)
Eli Lilly and Company (the "company" or "registrant" or "Lilly") was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. We discover, develop, manufacture, and market products in two business segments--human pharmaceutical products and animal health products. The mission of our human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Our vision is to make a significant contribution to humanity by improving global health in the 21st century. Most of the products we sell today were discovered or developed by our own scientists, and our success depends to a great extent on our ability to continue to discover, develop, and bring to market innovative new medicines. Our animal health business, operating through our Elanco division, develops, manufactures, and markets products for both food animals and companion animals. ... More ...
Where does LLY fit in the risk graph?
|Annual EPS Est:||$3.43|
|Quarterly EPS Est:||0.85|